Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

ABIVAX - Filing #2810976

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
112,000 EUR
EUR
EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
41 090 EUR
39 363 EUR
33 745 EUR
Current assets
285 972 EUR
36 181 EUR
75 485 EUR
Non-current liabilities
61 008 EUR
36 223 EUR
51 032 EUR
Current liabilities
70 042 EUR
32 132 EUR
32 265 EUR
Profit (loss)
147 740 EUR
147 740 EUR
EUR
EUR
EUR
EUR
EUR
60 740 EUR
EUR
60 740 EUR
60 740 EUR
EUR
EUR
42 452 EUR
EUR
42 452 EUR
Other comprehensive income
225,000 EUR
EUR
225,000 EUR
112,000 EUR
EUR
112,000 EUR
EUR
EUR
235,000 EUR
235,000 EUR
EUR
235,000 EUR
EUR
EUR
169,000 EUR
EUR
169,000 EUR
169,000 EUR
Comprehensive income
147 516 EUR
147 740 EUR
147 516 EUR
112,000 EUR
EUR
112,000 EUR
EUR
EUR
60 506 EUR
235,000 EUR
60 740 EUR
EUR
EUR
42 452 EUR
169,000 EUR
42 283 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.